Journal of Commercial Biotechnology — October 2009 issue now available

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 15, Issue 4


Intellectual property and biotechnology innovation: To protect or not protect? PDF
Yali Friedman


The correlation between medical tourism and biotechnology PDF
David G Vequist IV, Erika Valdez
The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview PDF
William Bains


Innovate America: The Technology Innovation Program at NIST PDF
Andrew S Klein, Mrunal S Chapekar
Valuation of complex license contracts PDF
Ralph Villiger, Boris Bogdan
How can pharmaceutical and biotechnology companies maintain a high profitability? PDF
Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel
Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry PDF
J Leslie Glick
Building biotechnology teams: Personality does matter PDF
Anne S York, Kim A McCarthy, Todd C Darnold
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement PDF
Rob Hanes, Damon Borich

Legal and Regulatory Updates

Legal and Regulatory Update PDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: Genomics & society: Legal, ethical and social dimensions PDF
Dominic Clark
Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace PDF
Arlen D Meyers
Book Review: Biotech funding trends: Insights from entrepreneurs and investors PDF
J Leslie Glick

Click here for reuse options!
Copyright 2009 Biotechblog

Leave a Reply

%d bloggers like this: